Status:
COMPLETED
The Oslo Stan vs Lactate Observational Study
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Haukeland University Hospital
Conditions:
Fetal Monitoring
Eligibility:
FEMALE
18-60 years
Brief Summary
The main aim of the study is to compare the clinical performance of two adjunctive methods to CTG in intrapartum fetal monitoring: FBS with measurement of scalp lactate and ST analysis of the fetal EC...
Detailed Description
We use Lactate as a standard adjunctive method in our hospital but we have STAN software available ( is demasked) in our CTG monitors. We will include all women in labour with an intern scalp monitori...
Eligibility Criteria
Inclusion
- Singleton pregnancy
- Cephalic presentation
- Gestational age ≥36+0 weeks at delivery
- Presence of antpartum or intrapartum risk factors for fetal hypoxia according to Norwegian guidelines and therefore indication for electronic fetal monitoring with scalp electrode .
Exclusion
- Multiple pregnancies
- Breech presentation
- Gestational age \< 36+0 weeks
- Contraindications for placement of a scalp electrode (HIV or HBV or HCV pos)
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
694 Patients enrolled
Trial Details
Trial ID
NCT04779294
Start Date
September 1 2018
End Date
October 31 2023
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0424